Karyotype plus NPM1 mutation status defines a group of elderly patients with AML (≥60 years) who benefit from intensive post-induction consolidation therapy
| Image |  |
|---|---|
| Description | scientific article published on 19 September 2016 |
| Author/s |
author: Michael Kundi Paul Knöbl Peter Valent Wolfgang R Sperr |
| Publication date | September 19, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |